Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis-Reference-Cited by-同舟云学术

Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis

Published:2016-05 Issue:1 Volume:95 Page:477-482
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Bush David A.,Smith Jason C.,Slater Jerry D.,Volk Michael L.,Reeves Mark E.,Cheng Jason,Grove Roger,de Vera Michael E.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. Primary liver cancer: World-wide incidence and trends;Bosch;Gastroenterology,2004

2. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

3. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial;Bush;Cancer,2011

4. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma;Kawashima;J Clin Oncol,2005

5. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma;Fukumitsu;Int J Radiat Oncol Biol Phys,2009

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi Panel;South Asian Journal of Cancer;2024-07-22

2. Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel;Journal of Vascular and Interventional Radiology;2024-06

3. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation;Surgical Clinics of North America;2024-02

4. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

5. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01